CME/CE

Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs

27:16

Faculty: Ashkan Abbey, MD Faculty: Rishi Singh, MD, FASRS

While anti-VEGF biologics have transformed outcomes in neovascular age-related macular degeneration (nAMD), real-world data continue to show that visual gains achieved in clinical trials are not consistently replicated in practice due to various reasons. As sustained-delivery tyrosine kinase inhibitors (TKIs) advance through late-stage…